AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Tacriva 0.03% Lotion

Prescription Icon
Prescription Required

Marketer

Rivan Pharma

Salt Composition

Tacrolimus (0.03% w/v)

Overview Tacriva 0.03% Lotion

Eczema (atopic dermatitis) is treated with Tacriva 0.03% Lotion, which reduces inflammation (skin redness and swelling) by modulating specific immune cell activity. This soothes itching and improves atopic dermatitis rashes. Apply Tacriva 0.03% Lotion externally, two to four times daily to affected areas, or as directed by a physician. Gently and evenly distribute the lotion until fully absorbed. Avoid over-application and avoid bandaging or covering treated skin. Consult your doctor if there's no improvement after two weeks, or if your condition worsens. Potential side effects include redness, headache, folliculitis, and application-site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally discouraged unless absolutely necessary.

Uses of Tacriva 0.03% Lotion

Managing atopic dermatitis

Major Benefits of Tacriva 0.03% Lotion:

Apply this medication topically only. Follow your physician's instructions regarding dosage and treatment length. Ensure thorough shaking before applying a uniform layer to the affected zone.

Common Side effects of Tacriva 0.03% Lotion:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacriva 0.03% Lotion:

Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Ensure thorough shaking before applying a uniform layer to the affected zone.

How Tacriva 0.03% Lotion works:

Immunosuppressant lotion, Tacriva 0.03%, reduces skin inflammation (redness and swelling) by modulating the activity of specific immune cells. This alleviates itching and enhances the appearance of rashes characteristic of atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacriva 0.03% Lotion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to recommending its use. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Applying Tacriva 0.03% Lotion while breastfeeding appears unlikely to pose a risk. Available data from human studies indicate minimal danger to the infant.

DrivingDrivingNone

No drug interaction identified.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No drug interactions identified.

What if you forget to take Tacriva 0.03% Lotion :

Should you forget a Tacriva 0.03% Lotion application, apply it immediately. Nevertheless, if your next scheduled application is imminent, omit the missed dose and resume your usual regimen.

Facts to Know About Tacriva 0.03% Lotion

LabelValue
Chemical Category Macrolide Antibiotics
Developing Habits No.
Treatment Category Cancer Medications
Action Category Calcineurin inhibitor immunosuppressants

FAQs on Tacriva 0.03% Lotion

Tacriva 0.03% Lotion is an immune-modulating medicine that primarily reduces immune system activity. It treats moderate to severe eczema (atopic dermatitis) in adults who haven't responded to or experienced side effects from steroid treatments. By targeting the overactive immune response responsible for the inflammation, itchiness, and dryness of atopic dermatitis, Tacriva 0.03% Lotion alleviates these symptoms.
Applying Tacriva 0.03% Lotion may cause mild to moderate skin irritation, including burning, itching, redness, warmth, pain, altered sensation, and rash at the application site. These side effects usually subside within a week. Treatment may also increase the risk of inflamed or infected hair follicles, cold sores, acne, and generalized herpes simplex infections.
Tacriva 0.03% Lotion offers safe and effective short-term atopic dermatitis treatment, demonstrating superior safety compared to other immunosuppressants. Minimal systemic absorption following topical application results in fewer side effects than oral immunosuppressants.
Tacriva 0.03% Lotion is not a controlled substance and does not have abuse potential. Controlled substances require authorization from both a doctor and regulatory authorities due to their potential for misuse.
Prolonged use of Tacriva 0.03% Lotion is associated with a heightened risk of lymphoma, a type of lymph node tumor. Studies indicate a small number of users of Tacriva 0.03% Lotion or similar treatments developed skin cancer or lymphoma. If using Tacriva 0.03% Lotion for over six weeks, or if your eczema worsens or fails to improve, consult your physician.
Tacriva 0.03% Lotion is a non-steroid medication that modulates the immune system. Primarily used for eczema, particularly atopic dermatitis, it avoids the skin thinning and other side effects associated with steroids.
Tacriva 0.03% Lotion
148
MRP 180
17% off